That the precautionary dose will not be a mix and match programme resolves worries of supply constraints. Nearly 90% of vaccine recipients have been jabbed with abundantly available Covishield, and even under-performing Bharat Biotech should...
from Times of India Opinion https://ift.tt/3zzFGvZ
No comments:
Post a Comment